MedPath

Transurethral Enucleation and Resection of Prostate versus Transvesical Prostatectomy for Prostate greater than 80ml: A Prospective Randomized Study

Completed
Conditions
benign proaste hyperplasia
Renal and Urogenital - Other renal and urogenital disorders
Registration Number
ACTRN12610000072011
Lead Sponsor
xie, keji
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
100
Inclusion Criteria

benign prostate hyperplasia (BPH) with prostate>80ml: The prostate volume is measured by transrectal ultrasound conform to this equation: the volume equals 0.52 × (L × W × H), where L is the maximum length (craniocaudal dimension), H is the maximum height (anteroposterior dimension), both were obtained from the sagittal plane, W is the maximum width (transverse dimension) obtained from the transverse plane.

Exclusion Criteria

neurologic problem and Bladder stone

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
International prostate symptom score(IPSS)[at 12 months after surgery];Quality of Life Scale (QOLS)[at 12 months after surgery]
Secondary Outcome Measures
NameTimeMethod
postvoid residual(PVR): PVR is measured by ultrasound or catheterization[at 12 months after surgery]
© Copyright 2025. All Rights Reserved by MedPath